The company resolved all worldwide patent infringement litigation with Arbutus and Genevant, incurring a $950 million accrual. This material event significantly impacted Q1 financials and cash flow, highlighting the high cost of intellectual property disputes.
Filing excerpt
On March 3, 2026, we entered into a settlement agreement with Arbutus and Genevant to resolve all patent infringement litigation pending worldwide.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
sec-10qlitigationMaterialGet every 10-Q signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/fb57b7f7-3841-4934-87c0-c2a5c330fdb0 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "fb57b7f7-3841-4934-87c0-c2a5c330fdb0",
"signal_type": "sec-10q",
"signal_subtype": "litigationMaterial",
"detected_at": "2026-05-05T08:48:22.452+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "The company resolved all worldwide patent infringement litigation with Arbutus and Genevant, incurring a $950 million accrual. This material event significantly impacted Q1 financials and cash flow, highlighting the high cost of intellectual property disputes.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Litigation settlement accrual",
"dollar_millions": 950
},
"summary": "Settled patent litigation with Arbutus and Genevant for $950M in Q1 2026.",
"excerpts": "On March 3, 2026, we entered into a settlement agreement with Arbutus and Genevant to resolve all patent infringement litigation pending worldwide.",
"relevance": 0.95,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000060/mrna-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Legal tech opportunity",
"signal_category": "risk",
"competitors_mentioned": [
"Arbutus Biopharma Corporation",
"Genevant Sciences GmbH"
]
}
}
curl https://signals.autobound.ai/v1/signals/fb57b7f7-3841-4934-87c0-c2a5c330fdb0 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.